NCT02407509
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02407509 |
| Title | Phase I Trial of VS-6766 Alone and in Combination With Everolimus (RAF/MEK) |
| Acronym | RAF/MEK |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Royal Marsden NHS Foundation Trust |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
CKB BOOST